×
GreekEnglish

×
  • Politics
  • Diaspora
  • World
  • Lifestyle
  • Travel
  • Culture
  • Sports
  • Cooking
Wednesday
24
Dec 2025
weather symbol
Athens 12°C
  • Home
  • Politics
  • Economy
  • World
  • Diaspora
  • Lifestyle
  • Travel
  • Culture
  • Sports
  • Mediterranean Cooking
  • Weather
Contact follow Protothema:
Powered by Cloudevo
> World

Revolutionary cancer treatment: 9 out of 10 patients with leukaemia were cured

More than nine out of ten participants with a severe form of leukaemia saw their symptoms completely vanish

Newsroom February 16 11:22

A revolutionary treatment of cancer that could stop the disease from ever coming back will soon become widely available, scientists said yesterday.

According to Sky News, US scientists developed a new cancer drug which offers hope of a lasting cure.

More than nine out of ten participants with a severe form of leukaemia saw their symptoms completely vanish.

Four out of five patients with some other blood cancers responded positively to the treatment and more than half ended up symptom free.

The technique involves the removal of immune cells called T-cells from patients and tagging them with “receptor” molecules that target cancer. Then, they are put back into the patient in an infusion.

The targeting molecules, known as chimeric antigen receptors or Cars, came from specially bred genetically engineered mice.

>Related articles

The sarcophagus over Chernobyl will not withstand a direct hit by a missile or drone, says the director of the

Russia and the US have not yet found solutions to “troublesome” issues in their relations, Moscow says

Learjet crashes in Ankara: Libya’s Chief of the General Staff, Mohammed Al-Haddad, dead

Once attached to the T-cells, they reduce the ability of the cancer to shield itself from the body’s natural immune system.

Lead scientist Professor Stanley Riddell, from the Fred Hutchinson Cancer Research Center in Seattle, US, said the results were among patients who were projected to have two to five months to live.

“This is extraordinary. This is unprecedented in medicine to be honest, to get response rates in this range in these very advanced patients.” he said.

Ask me anything

Explore related questions

> More World

Follow en.protothema.gr on Google News and be the first to know all the news

See all the latest News from Greece and the World, the moment they happen, at en.protothema.gr

> Latest Stories

The sarcophagus over Chernobyl will not withstand a direct hit by a missile or drone, says the director of the

December 23, 2025

US announces tariffs on microchips imported from China from 2027

December 23, 2025

Russia and the US have not yet found solutions to “troublesome” issues in their relations, Moscow says

December 23, 2025

Video of the French Navy raid on the ship of the Greek “Escobar”

December 23, 2025

Learjet crashes in Ankara: Libya’s Chief of the General Staff, Mohammed Al-Haddad, dead

December 23, 2025

Ryanair fined €256 million by Italy for abusing dominant market position

December 23, 2025

6th Meeting of Catechumens and distribution of catechetical material in Stockholm

December 23, 2025

The cost of blockades to the market reaches €200 million per week, with Thessaly suffering the greatest damage

December 23, 2025
All News

> Economy

US announces tariffs on microchips imported from China from 2027

To date, these products have been imported into the United States with zero tariffs, which, according to the US side, has disproportionately favoured Chinese industry at the expense of US industry.

December 23, 2025

Ryanair fined €256 million by Italy for abusing dominant market position

December 23, 2025

Decrease in container traffic in Piraeus, upward trends in other European ports of COSCO

December 23, 2025

Saks in the shadow of bankruptcy – In a difficult position despite raising billions

December 23, 2025

Properties linked to Jackie O’ Bar Mykonos face foreclosure procedures

December 23, 2025
Homepage
PERSONAL DATA PROTECTION POLICY COOKIES POLICY TERM OF USE
Powered by Cloudevo
Copyright © 2025 Πρώτο Θέμα